Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion | |
Li Q.; Chen C.; Chen X.; Han M.; Li J. | |
刊名 | Life Sciences |
2018 | |
卷号 | 207页码:1-8 |
关键词 | Dexmedetomidine Fibrosis Inflammation Renal ischemia reperfusion Senescence |
DOI | 10.1016/j.lfs.2018.05.003 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4583144 |
专题 | 山东大学 |
作者单位 | School of Medicine, Shandong University, Jinan, Shandong 250012, China, Department of Anesthesiology, Anhui Provincial Hospital, Hefei, 23000 |
推荐引用方式 GB/T 7714 | Li Q.,Chen C.,Chen X.,et al. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion[J]. Life Sciences,2018,207:1-8. |
APA | Li Q.,Chen C.,Chen X.,Han M.,&Li J..(2018).Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.Life Sciences,207,1-8. |
MLA | Li Q.,et al."Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion".Life Sciences 207(2018):1-8. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论